LINC 2020: Prestige Pilot study — Dr Michael Lichtenberg

(3:37)

LINC 2020: IVUS vs fluoroscopic guided recanalization — Dr Michael Lichtenberg

(2:23)

LINC 2020: Retrospective Analysis of the Tack® Device — Dr Michael Lichtenberg

(1:56)

LINC 2020: Paclitaxel exposure and dosage of DCBs for the treatment of PAD — Dr Peter Schneider

(9:33)

LINC 2020 | Sirolimus-Coated Balloon | Safe FUTURE Alternative to Treat Peripheral Vascular Disease

(10:19)

LINC 2020: Viewpoint - Prof Kostantinos Donas

(6:40)

LINC 2020: 4-year update from the ILLUMENATE trial — Prof Sean Lyden

(1:1econd)

LINC 2020 Interview | Concept Medical | Hello Future | Leipzig Germany

(8:30)

LINC 2020: IN.PACT Global Study: 150mm cohort — Prof Marianne Brodmann

(2:54)

LINC 2020: COMPARE-RCT of low dose vs high dose Paclitaxel CBs — Dr Sabine Steiner

(3:6)

LINC 2020: Budget impact model for the IN.PACT® AV access trial — Dr Robert Lookstein

(2:55)

LINC 2020: Stellarex® in the real-world — Dr Konstantinos Stavroulakis

(4:26)

LINC 2020: DCB outcomes in the femoropopliteal by vessel size — Dr Yoshimitsu Soga

(2:11)

LINC 2020: Safety analysis of the Lutonix® SFA DCB — Dr Kenneth Ouriel

(2:50)

LINC 2020: Clinical Application of the TrackCath System — Dr Daniela Branzan

(1:22)

LINC 2020 Conference

(1:49)

LINC 2020: Novel sirolimus-eluting nitinol stent can address “unmet need” of durability in the SFA

(3:20)